Literature DB >> 2968320

Role of L3T4+ T cells in host defense against Histoplasma capsulatum.

A M Gomez1, W E Bullock, C L Taylor, G S Deepe.   

Abstract

Cell-mediated immunity is critical in host resistance against the pathogenic fungus Histoplasma capsulatum. To explore the role of L3T4+ T cells in protection of mice against H. capsulatum infection, we examined the effect of in vivo treatment with anti-L3T4 monoclonal antibody (MAb) GK1.5 on the course of murine disseminated histoplasmosis. Treatment with anti-L3T4 antibody caused a profound and selective depletion of L3T4+ T cells that was associated with a significant increase in the number of H. capsulatum CFU recovered from the spleens of mice infected for 1 week. In addition, none of the infected mice treated with MAb GK1.5 survived a sublethal challenge with H. capsulatum yeasts. Histopathological examination of spleens from mice infected for 1 week revealed the presence of granulomatous inflammation in mice depleted of L3T4+ T cells and in infected controls. However, silver stains demonstrated that spleens of infected mice given MAb GK1.5 contained a greater number of yeasts than did spleens from infected controls. MAb GK1.5 did not cause reactivation of infection when administered for 2 weeks beginning 4 weeks after inoculation of Histoplasma yeasts. MAb GK1.5 did not alter the functional properties of murine macrophages as measured by antigen presentation, production of interleukin-1 in response to lipopolysaccharide, and phagocytosis of H. capsulatum yeasts. These results suggest that the L3T4+ T-cell subset is an essential constituent of the cell-mediated immune defense against H. capsulatum infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968320      PMCID: PMC259463          DOI: 10.1128/iai.56.7.1685-1691.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection.

Authors:  R C Mathew; D L Boros
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

3.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

4.  Significance of thymus-derived lymphocytes in immunity elicited by immunization with ribosomes or live yeast cells of Histoplasma capsulatum.

Authors:  R P Tewari; D K Sharma; A Mathur
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

5.  Histoplasma capsulatum infection in nude mice.

Authors:  D M Williams; J R Graybill; D J Drutz
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies.

Authors:  R P Artz; W E Bullock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  Effect of antilymphocyte serum on animals experimentally infected with Histoplasma capsulatum or Cryptococcus neoformans.

Authors:  D M Adamson; G C Cozad
Journal:  J Bacteriol       Date:  1969-12       Impact factor: 3.490

8.  Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones.

Authors:  G S Deepe; J G Smith; G Sonnenfeld; D Denman; W E Bullock
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

9.  Species heterogeneity in macrophage expression of the CD4 antigen.

Authors:  P R Crocker; W A Jefferies; S J Clark; L P Chung; S Gordon
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  28 in total

1.  Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.

Authors:  Holly L Allen; George S Deepe
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

2.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

3.  Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response.

Authors:  Mark R Scheckelhoff; George S Deepe
Journal:  J Infect Dis       Date:  2006-02-09       Impact factor: 5.226

4.  T cells require tumor necrosis factor-alpha to provide protective immunity in mice infected with Histoplasma capsulatum.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Infect Dis       Date:  2005-12-05       Impact factor: 5.226

5.  Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.

Authors:  P Connolly; L J Wheat; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; J Goldberg; E Brizendine; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.

Authors:  Alison Coady; Anita Sil
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

7.  Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells.

Authors:  G S Deepe
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis.

Authors:  F J Gomez; J A Cain; R Gibbons; R Allendoerfer; G S Deepe
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Protective efficacy of a 62-kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells.

Authors:  F J Gomez; A M Gomez; G S Deepe
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

10.  Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone.

Authors:  R Allendoerfer; D M Magee; G S Deepe; J R Graybill
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.